A review on the roles and molecular mechanisms of MAFG-AS1 in oncogenesis

Pathol Res Pract. 2023 Mar:243:154348. doi: 10.1016/j.prp.2023.154348. Epub 2023 Jan 30.

Abstract

Long non-coding RNAs (lncRNAs) have more than 200 nucleotides and do not encode proteins. At the same time, they can regulate various biological functions and therefore play an essential role as oncogenes or tumor suppressors in human cancers. MAFG-AS1 is an antisense RNA of MAF BZIP Transcription Factor G (MAFG) located at chromosome 17q25.3 head-to-head with the MAFG encoding gene containing a transcript size of 1895 bp. Accumulating evidence shows that MAFG-AS1 is overexpressed in many cancers, functions as an oncogene, and is significantly associated with poor clinical characteristics and prognosis. In this review, we first discuss the recent literature regarding the role of MAFG-AS1 in different cancers as well as its diagnostic and prognostic values. Then we will provide insights into its biological functions, such as its role in cancer progression, competing endogenous RNA (ceRNA) activity, regulation of EMT, glycolysis, energy metabolism, transcription factors, proteasomal degradation, and signaling pathways.

Keywords: Cancer; MILIP; MiRNA; Non-coding-RNA; Oncogene; Prognosis; lncRNA.

Publication types

  • Review

MeSH terms

  • Carcinogenesis / genetics
  • Cell Proliferation / genetics
  • Cell Transformation, Neoplastic / genetics
  • Gene Expression Regulation, Neoplastic / genetics
  • Humans
  • MafG Transcription Factor / genetics
  • MafG Transcription Factor / metabolism
  • MicroRNAs* / genetics
  • Neoplasms* / genetics
  • Oncogenes
  • RNA, Antisense / metabolism
  • RNA, Long Noncoding* / metabolism
  • Repressor Proteins / genetics

Substances

  • RNA, Antisense
  • RNA, Long Noncoding
  • MicroRNAs
  • MAFG protein, human
  • Repressor Proteins
  • MafG Transcription Factor